Ercüment Ovalı
Impact in
- Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms
- Genetics top 5%
- Mesenchymal stem cell research
Papers in
- Hematology 23
- Hematopoietic Stem Cell Transplantation 7
- Blood Coagulation and Thrombosis Mechanisms 6
- Acute Myeloid Leukemia Research 5
- Genetics 17
- Mesenchymal stem cell research 12
- Co-authors
- Orhan DeğerMehmet SönmezSerdar Bedii OmayCihangir EremMustafa YılmazFahri Uçarİsmet DOĞANZeynep Etı
- Journals
- Pediatric Transplantation (2 papers)Journal of Enzyme Inhibition and Medicinal Chemistry (2 papers)Chemotherapy (2 papers)Anesthesia & Analgesia (2 papers)Cephalalgia (1 paper)
- Partner nations
- TürkiyeUnited StatesUnited Kingdom
In The Last Decade
Ercüment Ovalı
82 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 107
- Hematology 234
- Genetics 210
- Internal Medicine 43
- Rheumatology 166
- Urology 66
Countries citing papers authored by Ercüment Ovalı
This map shows the geographic impact of Ercüment Ovalı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ercüment Ovalı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ercüment Ovalı more than expected).
Fields of papers citing papers by Ercüment Ovalı
This network shows the impact of papers produced by Ercüment Ovalı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ercüment Ovalı. The network helps show where Ercüment Ovalı may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ercüment Ovalı, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 10 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 0 | |
| 7 | 2021 | 27 | |
| 8 | 2020 | 14 | |
| 9 | 2020 | 9 | |
| 10 | 2020 | 6 | |
| 11 | 2020 | 19 | |
| 12 | SUBMACULAR ALLOGENEIC ECTO-MESENCHYMAL STEM CELL TRANSPLANTATION IN RETINITIS PIGMENTOSA: ONE-YEAR RESULTS | 2015 | 1 |
| 13 | 2014 | 49 | |
| 14 | Kök Hücre Biyolojisi | 2011 | 1 |
| 15 | 2011 | 15 | |
| 16 | 2007 | 17 | |
| 17 | 2003 | 6 | |
| 18 | Akut miyokard infarktüslü hastalarda Faktör V Leiden mutasyonunun prognoz üzerine etkisi | 2001 | 1 |
| 19 | Effects of Angiotensin Converting Enzyme Inhibitors in Healthy Rats and in Rats With Carbon Tetrachloride-Induced Toxic Hepatitis | 2000 | 5 |
| 20 | 1999 | 55 |
About Ercüment Ovalı
Ercüment Ovalı is a scholar working on Hematology, Genetics, Hepatology, Toxicology and Oncology, having authored 85 papers that have together received 1.2k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (12 papers), Hematopoietic Stem Cell Transplantation (7 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers), Tissue Engineering and Regenerative Medicine (5 papers), Acute Myeloid Leukemia Research (5 papers), Immune Cell Function and Interaction (4 papers), Immunotherapy and Immune Responses (4 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Hematology (234 citations), Genetics (210 citations), Internal Medicine (43 citations), Rheumatology (166 citations) and Urology (66 citations). Ercüment Ovalı has collaborated with scholars based in Türkiye, United States and United Kingdom. Frequent co-authors include Orhan Değer, Mehmet Sönmez, Serdar Bedii Omay, Cihangir Erem, Mustafa Yılmaz, Fahri Uçar, İsmet DOĞAN, Zeynep Etı, Murat Ertürk and Mehmet Veli Karaaltın. Their work appears in journals such as Pediatric Transplantation, Journal of Enzyme Inhibition and Medicinal Chemistry, Chemotherapy, Anesthesia & Analgesia and Cephalalgia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.